COVID Vaccine Authorization Changes Without Advisory Committee Becoming More Common

 
• By Derrick Gingery
  
Vaccine booster
The change in the time between the Pfizer/BioNTech primary series and booster may create more confusion for recipients and providers. • Source: Alamy

More from Vaccines

More from Pink Sheet